Summary: Chronic pain and depression often go hand-in-hand, but for some, the brain remains remarkably resilient. A groundbreaking study explains why.
By mapping the “control center” of emotional regulation—the hippocampus—scientists discovered that depression isn’t an inevitable result of pain, but rather the result of a biological “tipping point” involving brain inflammation and neural adaptation.
Key Facts & Statistics
- The 20% Threshold: Chronic pain affects over 20% of adults worldwide. While it is a major driver of depression, many patients never develop mood disorders.
- The Resilience Marker: Patients with chronic pain who did not have depression showed larger hippocampal volume and increased activity, suggesting their brains mounted a protective, compensatory response.
- The Dentate Gyrus Hub: A specific subregion called the dentate gyrus—where new neurons are born—acts as the primary regulator for pain-related stress.
- The Microglia Switch: In resilient individuals, new neurons stay active to buffer stress. In those who develop depression, brain immune cells (microglia) become abnormally activated, triggering inflammation that disrupts neural communication.
- Progressive Change: The study found that these brain changes aren’t always pre-existing; they are driven by the experience of prolonged pain itself over time.
Source: University of Warwick
Scientists have uncovered a brain mechanism that may explain why chronic pain leads to depression in some people but not others, according to research published in Science.
The findings challenge the idea that depression is an inevitable consequence of long-term pain.
By combining large-scale human brain imaging with animal experiments, the researchers found that persistent pain drives progressive changes in the hippocampus (a brain region best known for its role in memory), which shapes whether people develop depression over time or remain emotionally resilient.
“Chronic pain frequently develops into depression or anxiety, but until now we haven’t understood why this happens to some people and not others,” said co-lead author Professor Jianfeng Feng of the University of Warwick.
“Our findings suggest that the hippocampus acts as a control centre that helps the brain regulate emotional responses to long-term pain. Depression is not inevitable – it depends on how this system responds over time.”
The brain’s early response to pain
Chronic pain affects more than 20% of adults worldwide and is strongly associated with anxiety and depression. Yet many people with persistent pain do not develop these conditions, and the biological reasons for this difference have remained unclear.
To investigate, the researchers analysed brain scans from large population cohorts, including data from the UK Biobank. They found that people living with chronic pain but without depression tended to show slightly larger hippocampal volume and increased activity in this brain region. These changes were accompanied by better performance in certain learning and memory tasks, suggesting the brain may initially mount a compensatory response to persistent pain.
In contrast, individuals experiencing both chronic pain and depression showed reduced hippocampal volume, disrupted activity, and poorer cognitive performance. Longitudinal analyses indicated that these changes developed progressively over time.
“The fact that these changes emerge gradually suggests they are driven by the experience of prolonged pain itself,” Professor Feng added. “This isn’t simply a pre-existing vulnerability; it’s something the brain is doing in response to ongoing pain.”
From resilience to vulnerability
To understand how these changes unfold, the researchers conducted parallel studies in animal models of chronic neuropathic pain.
They observed a clear progression of behavioural effects. Increased pain sensitivity appeared first, followed by anxiety-like behaviour, and later by depression-like symptoms. These behavioural changes were accompanied by gradual alterations in hippocampal structure and activity, showing how prolonged pain can reshape brain circuits involved in emotional regulation.
A small subregion of the hippocampus known as the dentate gyrus – one of the few areas of the adult brain where new neurons continue to form – emerged as a key regulatory hub.
Early in the course of chronic pain, newly generated neurons in the dentate gyrus became highly active, suggesting the brain initially attempts to adapt to ongoing stress. Over time, however, immune cells in the brain called microglia became abnormally activated. This disrupted normal communication between neurons and microglia marked a tipping point from adaptive brain responses to dysfunctional signalling.
When the researchers suppressed this abnormal microglial activity in animal models, depression-like behaviours improved while overall brain function remained stable. The findings suggest that targeting microglial inflammation in the hippocampus could help prevent depression in people living with persistent pain, particularly if treatment is introduced early.
“What this shows is that the brain is not simply overwhelmed by chronic pain,” Professor Feng concluded.
“It actively tries to regulate emotional wellbeing. When that regulatory system remains balanced, people can stay resilient. When it becomes disrupted, particularly by inflammation in the hippocampus, depression can emerge. Understanding this process opens new possibilities for early intervention.”
Key Questions Answered:
A: It’s more than that—it’s a physical structural change. This study shows that prolonged pain actually reshapes the brain’s circuits. It starts as a “learning” process where the brain tries to adapt, but if the pain continues too long, the brain’s immune system (microglia) overreacts, causing the “depression switch” to flip.
A: The research suggests a “window of opportunity.” Because these changes happen progressively, early intervention is key. By targeting microglial inflammation in the hippocampus before it reaches that tipping point, doctors might be able to keep the brain in a “resilient” state even if the physical pain persists.
A: Interestingly, yes. The study found that resilient patients had better performance in learning and memory tasks. Since the hippocampus handles both memory and emotion, a “stronger” hippocampus seems to be better at multitasking—managing the signal of chronic pain while keeping emotional health stable.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this depression and pain research news
Author: Matt Higgs
Source: University of Warwick
Contact: Matt Higgs – University of Warwick
Image: The image is credited to Neuroscience News
Original Research: Closed access.
“From chronic pain to depression: Neurogenesis-driven microglial remodeling in the hippocampal dentate gyrus” by Ming Ding, Shitong Xiang, Yuqing Zhang, Lei Wei, Yuanfeng Weng, Xueting Zhang, Yiling Ni, Yuwen Zhang, Qianfeng Wang, Ruiqing Hou, Huaihao Du, Ka Kei Chio, Wei Zhang, He Wang, Tianye Jia, Yi Wu, Jianfeng Feng, Trevor W. Robbins, and Xiao Xiao. Science
DOI:10.1126/science.aee6177
Abstract
From chronic pain to depression: Neurogenesis-driven microglial remodeling in the hippocampal dentate gyrus
INTRODUCTION
Chronic pain is a leading risk factor for depression and anxiety, yet the brain mechanisms that convert persistent sensory distress into affective dysfunction remain unclear.
Neuroimaging studies have implicated the hippocampus in both pain and mood regulation, but it is unknown whether hippocampal alterations precede, accompany, or result from the emergence of affective symptoms.
Resolving this temporal and mechanistic relationship is essential for explaining individual vulnerability to depression in chronic pain and for identifying intervention points that can prevent this transition.
RATIONALE
We hypothesized that chronic pain induces a staged remodeling process, rather than a uniform degenerative change, within the hippocampus. Specifically, we proposed that the dentate gyrus serves as a critical gate where persistent nociceptive input is initially accommodated through adaptive plasticity but later diverted into maladaptive circuit destabilization by interactions between adult-born neurons and microglia.
RESULTS
Integrating longitudinal human neuroimaging data from the UK Biobank with rodent models of neuropathic pain, we identified a conserved biphasic trajectory of hippocampal remodeling.
During early stages of chronic pain, hippocampal volume increased and hippocampal-dependent cognitive performance improved, consistent with an adaptive response. As pain persisted, this phase transitioned to hippocampal atrophy, cognitive decline, and the emergence of anxiety- and depression-like behaviors.
At the cellular level, early chronic pain selectively increased activity of newborn neurons within the dentate gyrus and triggered targeted recruitment and remodeling of microglia in the neurogenic niche. These cell-type–specific changes progressively amplified local circuit excitability and disrupted network balance, marking a transition from adaptive hippocampal plasticity to maladaptive circuit remodeling.
Functionally, distinct modes of dentate gyrus modulation produced divergent outcomes: Suppressing newborn neuron activity alleviated affective symptoms but impaired cognition, whereas microglial modulation prevented anxiety- and depression-like behaviors while preserving cognitive function. Together, these findings identify microglia as a key regulator of the pain-to-depression transition.
CONCLUSION
By resolving distinct modes of dentate gyrus modulation, we show that microglia act as critical and therapeutically tractable regulators of the transition from chronic pain to affective disorders.
Our findings reveal that this transition is governed not by hippocampal hyperactivity per se but rather by microglia-dependent remodeling that determines whether adaptive plasticity is sustained or diverted into maladaptive circuit states.
Targeting microglial activation preserves hippocampal structure and cognitive function while preventing affective pathology, positioning microglia as a selective leverage point for interrupting the progression from chronic pain to mood disorders.
